This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets.
Clinical trial NCT01750931 · COMPLETED
Trial details
- NCT number
- NCT01750931
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-12
- Primary completion
- 2013-10-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.